Announcing the Tadej Pogačar Cancer Research Foundation
We are proud to announce the launch of the Tadej Pogačar Cancer Research Foundation. What makes our work different? We are focused on cancer metabolism, which we believe is key to fighting the disease, with our recent work showing immense promise. Tadej is excited to launch the Foundation to promote and support this new area of cancer research.
The Tadej Pogačar Cancer Research Foundation was founded to expand on promising, but underfunded research in cancer metabolism, which we believe is the key to fighting the disease. Specifically, we will seek out and fund novel research targeting the synergy of exercise, metabolism, and cancer treatment, and how exercise can increase survival for people battling cancer today. We are dreamers, we are fighters, we will never give up – if it is possible to win the Tour de France, we believe The Tadej Pogačar Cancer Foundation can help find a cure for cancer.
About the Foundation
Tadej Pogačar is a two-time Tour de France champion cyclist from Slovenia, the 2nd youngest-ever winner of the race and multiple Olympic medalist. He is a member of the UAE Team Emirates professional cycling team and is ranked the No. 1 cyclist in the world.. Tadej is proud to launch the Foundation and is highly committed to our mission and will bring the full focus and drive of his profession and brand to meet our goals. Read more about Tadej on his new personal web site
Foundation Vision & Goals
– The Tadej Pogacar Cancer Research Foundation will be instrumental in the field of research in cancer metabolism, a breakthrough field began in 1923, but forgotten for sixty years and that is now experiencing a renaissance.
– The Tadej Pogacar Cancer Research Foundation will prioritize the most innovative concepts in cancer metabolism and will fund multiple research groups around the world with the aim to develop novel diagnosis and therapeutics to contribute to help finally corner cancer.
– The area of exercise oncology is receiving significant attention in recent years as the effects of exercise for both cancer patients and survivors seem to be significantly beneficial. “Exercise as medicine” may elicit significant improvements at the metabolic level, which could improve cancer outcomes and improve survivorship.
– It has been established exercise can reduce risk of cancers, but the mechanisms by which exercise can improve cancer outcomes and be used as a therapeutic needs further study. Individualized prescription of exercise may be of great importance to achieve the ideal benefits as a therapeutic component in cancer patients and survivors.
Learn more about cancer research:
Lactate metabolism in human health and disease (comprehensive)
Xiaolu Li, Yanyan Yang, et al.
Nature, Signal Transduction and Targeted Therapy 7, Article number: 305 (2022)
Why the Tour de France could be useful for cancer research
Der Tagesspiegel, July 3, 2021
Metabolomics: The Science Behind a Tour de France Winner
Drug Discovery World
Cancer as a mitochondrial metabolic disease
Seyfried, T. N. Frontiers in cell and developmental biology. 2015 Jul 7;3:43.
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
Science 22 May 2009, Vol 324, Issue 5930, pp. 1029-1033
Metabolism and cancer: the future is now
British Journal of Cancer, Volume 122, December 10, 2019, pp. 133–135
Fundamental cancer metabolism dogma revisited
Massachusetts General Hospital Press Release, March 22, 2022
Exercise—A Panacea of Metabolic Dysregulation in Cancer: Physiological and Molecular Insights
Steffen H. Raun, Lewis C. Cantley, and Craig B. Thompson
International Journal of Molecular Sciences, April, 2021; 22(7): 3469.
Molecular Mechanisms Linking Exercise to Cancer Prevention and Treatment
Pernille Hojman, JulieGehl, Jesper F.Christensen, and Bente K.Pedersen
Cell Metabolism, Volume 27, Issue 1, 9 January 2018, pp. 10-21
Lactate and Cancer Risk: The Role of Strenuous Exercise
Chris Carmichael, CEO/Head Coach of CTS
For further information please contact us